List of bibliographic references
Number of relevant bibliographic references: 41.
[0-20] [
0 - 20][
0 - 41][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000013 (2005) |
Patricia Woo [Royaume-Uni] ; Nicholas Wilkinson [Royaume-Uni] ; Anne-Marie Prieur [France] ; Taunton Southwood [Royaume-Uni] ; Valentina Leone [Royaume-Uni] ; Polly Livermore [Royaume-Uni] ; Helena Wythe [Royaume-Uni] ; David Thomson [Royaume-Uni] ; Tadamitsu Kishimoto [Japon] | Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement |
| 000030 (2006) |
Norihiro Nishimoto [Japon] ; Tadamitsu Kishimoto | Interleukin 6: from bench to bedside. |
| 000042 (2007) |
Norihiro Nishimoto [Japon] ; Jun Hashimoto ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Norikazu Murata ; Désirée Van Der Heijde ; Tadamitsu Kishimoto | Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. |
| 000070 (2008) |
Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Yukoh Aihara ; Shuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto | Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. |
| 000074 (2008) |
Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto | The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis. |
| 000110 (2009) |
Norihiro Nishimoto [Japon] ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Junichi Azuma ; Tadamitsu Kishimoto | Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. |
| 000137 (????) |
Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi ; Tadamitsu Kishimoto | Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti-interluekin-6 receptor antibody. |
| 000189 (2010) |
Atsushi Ogata [Japon] ; Masahide Mori ; Shoji Hashimoto ; Yukihiro Yano ; Takeya Fujikawa ; Mari Kawai ; Yusuke Kuwahara ; Toru Hirano ; Junsuke Arimitsu ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Souichirou Yokota ; Tadamitsu Kishimoto ; Ichiro Kawase ; Toshio Tanaka | Minimal influence of tocilizumab on IFN-gamma synthesis by tuberculosis antigens. |
| 000194 (2009) |
Toshio Tanaka [Japon] ; Yusuke Kuwahara ; Yoshihito Shima ; Toru Hirano ; Mari Kawai ; Masako Ogawa ; Junsuke Arimitsu ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu Kishimoto | Successful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab. |
| 000198 (2010) |
Toshio Tanaka ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu Kishimoto | Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab. |
| 000238 (2010) |
Keisuke Hagihara ; Ichiro Kawase ; Toshio Tanaka ; Tadamitsu Kishimoto | Tocilizumab ameliorates clinical symptoms in polymyalgia rheumatica. |
| 000283 (2010) |
Yoshihito Shima [Japon] ; Yusuke Kuwahara ; Hiroyuki Murota ; Shun Kitaba ; Mari Kawai ; Toru Hirano ; Junsuke Arimitsu ; Masashi Narazaki ; Keisuke Hagihara ; Atsushi Ogata ; Ichiro Katayama ; Ichiro Kawase ; Tadamitsu Kishimoto ; Toshio Tanaka | The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab. |
| 000285 (2010) |
Shumpei Yokota [Japon] ; Tadamitsu Kishimoto | Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis. |
| 000338 (2011) |
Sumiyuki Nishida [Japon] ; Tomio Kawasaki ; Hirokazu Kashiwagi ; Atsuyoshi Morishima ; Yoshihiro Hishitani ; Mari Kawai ; Toru Hirano ; Taeko Ishii ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Yoshihiro Oka ; Tadamitsu Kishimoto ; Toshio Tanaka | Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab. |
| 000351 (2011) |
Yoshihito Shima [Japon] ; Tetsuya Tomita ; Taeko Ishii ; Atsuyoshi Morishima ; Yuichi Maeda ; Atsushi Ogata ; Tadamitsu Kishimoto ; Toshio Tanaka | Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis. |
| 000367 (2011) |
Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu Kishimoto | Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases. |
| 000382 (2011) |
Masashi Narazaki ; Keisuke Hagihara ; Yoshihito Shima ; Atsushi Ogata ; Tadamitsu Kishimoto ; Toshio Tanaka | Therapeutic effect of tocilizumab on two patients with polymyositis. |
| 000403 (2012) |
Tomoyuki Imagawa [Japon] ; Shumpei Yokota ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Hiroyuki Imanaka ; Yasuhito Nerome ; Naomi Iwata ; Takuji Murata ; Mari Miyoshi ; Norihiro Nishimoto ; Tadamitsu Kishimoto | Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis. |
| 000414 (2012) |
Toru Hirano [Japon] ; Nobuyuki Ohguro ; Satoshi Hohki ; Keisuke Hagihara ; Yoshihito Shima ; Masashi Narazaki ; Atsushi Ogata ; Kazuyuki Yoshizaki ; Atsushi Kumanogoh ; Tadamitsu Kishimoto ; Toshio Tanaka | A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab. |
| 000452 (2012) |
Toshio Tanaka [Japon] ; Masashi Narazaki ; Tadamitsu Kishimoto | Therapeutic targeting of the interleukin-6 receptor. |
| 000509 (2012) |
Toshio Tanaka [Japon] ; Tadamitsu Kishimoto | Immunotherapeutic implication of IL-6 blockade. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Tadamitsu Kishimoto"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i \
-Sk "Tadamitsu Kishimoto" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Ncbi
|étape= Checkpoint
|type= indexItem
|index= Author.i
|clé= Tadamitsu Kishimoto
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021 |  |
